Cbre 2025 Life Sciences Outlook

Cbre 2025 Life Sciences Outlook. Cbre 2024 Life Sciences Outlook Alidia Thomasine An uptick in venture funding in Q4 2022 was a hopeful sign for employment stabilization later this year since employment changes generally mirror funding changes after a two-quarter lag. Looking at 2025, CBRE and Cushman & Wakefield are forecasting.

According to this report, CBRE expects many of these same factors that benefited the sector in Q4 to contribute to the. Lab/R&D leasing activity trended higher in 2024 (e.g., a 41% year-over-year increase in Q3) and demand should continue to improve in 2025..

Cbre 2024 Life Sciences Outlook Alidia Thomasine

Various drivers of life sciences industry expansion appear well entrenched, acting as a. Life Sciences Outlook highlights continued growth driven by key factors such as an improving economy, robust sector employment, and a more favorable capital market environment economy, improving capital markets and growing life sciences employment are supporting momentum in several lab/R&D real estate indicators

CBRE's 2024 U.S. Life Sciences Outlook Industry expected to thrive. Life Sciences Outlook provides investors and occupiers alike with valuable insights to where the market is headed this year. Previous cycles show that any slowdown in life sciences employment likely won't be as severe as that of the broader economy

CBRE's 2024 U.S. Life Sciences Outlook Industry expected to thrive. Looking at 2025, CBRE and Cushman & Wakefield are forecasting. Lab/R&D leasing activity trended higher in 2024 (e.g., a 41% year-over-year increase in Q3) and demand should continue to improve in 2025..